have we got a dud?
“For the vaccine from AstraZeneca, the data available and evaluated to date are not yet sufficient for approval,” SwissMedic said on Wednesday. "In order to obtain additional data on safety, efficacy and quality, data from new studies are required."
https://www.ft.com/content/e20c3070-51e4-3ebf-9eaf-87abe7778188
“For the vaccine from AstraZeneca, the data available and evaluated to date are not yet sufficient for approval,” SwissMedic said on Wednesday. "In order to obtain additional data on safety, efficacy and quality, data from new studies are required."
https://www.ft.com/content/e20c3070-51e4-3ebf-9eaf-87abe7778188